## Abstract Transforming growth factor (TGF‐β1) is a potent inducer of chondrogenesis and stimulant of cartilage extracellular matrix (ECM) synthesis. Tissue inhibitor of metalloproteinases‐3 (TIMP‐3) is located in ECM and is the major inhibitor of matrix metalloproteinases (MMPs) and aggrecanase,
Requirement of phosphatidylinositol 3-kinase/Akt signaling pathway for regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-β in human chondrocytes
✍ Scribed by Hamid Yaqoob Qureshi; Rasheed Ahmad; Judith Sylvester; Muhammad Zafarullah
- Book ID
- 113528073
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 940 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0898-6568
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The balance between matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) regulates extracellular matrix turn-over in normal animal development, cancer cell metastasis, atherosclerotic plaque rupture and erosion of arthritic cartilage. Transforming growth factor beta (
A complex interplay between enzymes involved in extracellular matrix formation and their inhibitors is thought to control organogenesis during mammalian development. Disturbance of this balance may result in a wide range of diseases, including macular degeneration, arthritis, and tumor metastases. I